The company
A Swiss producer with scalable infrastructure, AI-supported cultivation and full traceability.
Provided by certified partners · introduced by AvantGardeMarketing communication
Medical cannabis — Swiss producer
Become a shareholder in a GACP-certified Swiss producer of medical cannabis near the German border, with full seed-to-sale traceability.
- Horizon
- 3–4 years +
- Entry ticket
- from CHF 5,000
- Asset
- Unlisted company shares
- Liquidity
- Very low
Where required, the prospectus and key information document are available free of charge on request from AvantGarde.
Satellite allocations
Partner selected by Steve LéchaireFive checks before a partner is introduced
3–4 years +horizon
How it works
Three steps, plainly explained
The market
Medical use is legal in more than 40 countries; Germany, Europe’s largest market, relies on imports.
Your stake
You acquire shares in the company and take part in its development.
What you actually own
Unlisted shares in a Swiss company.
Provided by a specialised partner, with whom the contract is concluded directly. AvantGarde introduces you and accompanies you; it does not hold client funds.
Why no return figures here
Partner projections are estimates, not promises. You receive them with all costs and risks, in writing, after the partner has assessed your situation — never as a headline.
Risks you should know
Read this before the opportunity
A young company: start-up shares can lose their entire value.
Cannabis regulation can change in either direction.
Unlisted shares are hard to sell.
Dividends are not guaranteed.
It may fit if…
- ✓You accept venture-type risk on a small amount
It is not for you if…
- ✕This would be more than a small part of your assets
- ✕You need liquidity
How Steve selects
Five checks before we introduce a partner
01
Partner & track record
Who runs it, for how long, with which references and audited accounts.
02
Legal structure
What exactly you own, in whose name, and under which law.
03
All-in costs
Entry, running and exit costs — added up, in writing.
04
Exit route
How and when you can get out, and what happens if you need to earlier.
05
Fit in your plan
Size, horizon and liquidity checked against your pension, property and reserves.
“I only present an investment after I have understood how it can go wrong. If I would not explain it to my own family, it is not on this list.”
Steve Léchaire · Founder, banking economist dipl. ES · 20+ years at UBS, in insurance and real estate
“Tangible, sustainable and authentic assets that combine tradition and innovation.”Cédric Favre · client review on avantgarde-investment.ch
Request the dossier
Get the full Medical cannabis — Swiss producer dossier
You receive the partner documentation, all-in costs and risks — then a call with Steve to see whether it fits your plan at all. No obligation.
- 1Four questions, one minute
- 2Steve replies personally within one working day
- 3Assessment with the partner before anything is signed
Steve LéchaireARIF member (AML self-regulation) · Ombud Finance Suisse
Related solutions
More in real assets & alternatives
AlternativesScotch whisky casks
Own casks of Scotch whisky maturing in bonded warehouses in Scotland — a tangible asset whose character, and rarity, grow with age.
5–7 yearsper cask, on request
Discover→
AlternativesRum casks
Premium rum from Panama, Jamaica and Barbados, ageing in cask — a younger, rarer market than whisky, with the same tangible logic.
5–10 yearsper cask, on request
Discover→
AlternativesApple balsamic vinegar casks
A cask of artisanal apple balsamic vinegar, aged into a premium culinary product — a niche, tangible asset.
5–10 yearsper cask, on request
Discover→